Managing Anxiety in a Patient with Dry Cough
For a patient with anxiety who also has a dry cough, lorazepam is recommended as the first-line medication due to its dual benefits of treating anxiety while not exacerbating cough symptoms. 1
Medication Selection Algorithm
First-line option: Benzodiazepines
- Lorazepam 0.5-1 mg orally four times daily as needed (maximum 4 mg in 24 hours)
- For elderly or debilitated patients: 0.25-0.5 mg (maximum 2 mg in 24 hours)
- Oral tablets can be used sublingually for faster onset 1
Second-line option: Buspirone
Avoid medications that may worsen cough:
- Opioid-based anxiolytics like codeine should be used cautiously as they may cause respiratory depression
- SSRIs may cause dry mouth which can exacerbate cough symptoms
Managing the Dry Cough Component
If the cough is particularly troublesome and requires specific treatment:
Non-pharmacological approaches:
- Simple non-drug measures such as honey (teaspoon as needed) 1
- Adequate hydration and humidification
Over-the-counter options:
For refractory cough:
Special Considerations
Anxiety-Cough Relationship
Recent evidence shows that anxiety and cough have a bidirectional relationship. Patients with anxiety report more severe cough symptoms 5, and 43% of patients with chronic refractory cough screen positive for anxiety 6. Addressing anxiety may improve cough perception and severity.
Monitoring and Follow-up
- Assess response to benzodiazepines within 24-48 hours
- If using buspirone, explain the delayed onset of action to ensure compliance 3
- Monitor for sedation with benzodiazepines, especially when initiating therapy
- For long-term anxiety management, periodically reassess the need for continued medication 2, 7
Cautions
- Benzodiazepines should be used for short-term management due to risk of dependence
- Buspirone has been safely used for up to one year without withdrawal symptoms upon discontinuation 7
- Avoid codeine-containing preparations when possible due to side effect profile and limited efficacy compared to alternatives 1, 4
By addressing both the anxiety and cough symptoms simultaneously, this approach optimizes treatment outcomes while minimizing adverse effects and potential drug interactions.